Scott E. Strome, M.D.
Scott E. Strome, M.D., a nationally recognized head and neck surgeon and researcher studying novel ways to harness the body’s immune system to fight cancer, has been appointed chairman of the newly created Department of Otorhinolaryngology-Head and Neck Surgery at the University of Maryland School of Medicine. He is also chief of Otorhinolaryngology at the University of Maryland Medical Center. The department provides patient care, research and training in conditions that affect the ear, nose and throat.
A graduate of Dartmouth College and Harvard Medical School, Dr. Strome comes to the University of Maryland from the Mayo Clinic in Rochester, Minn., where he was an associate professor of otorhinolaryngology and oversaw a large translational research program dedicated to bringing advances in the laboratory to the patient’s bedside.
Dr. Strome’s clinical interests include thyroid, salivary gland and laryngeal malignancies, melanoma, and head and neck reconstruction. He has developed a new peptide vaccine targeting human papilloma virus 16, a major cause of head and neck cancer. The vaccine will be tested later this year in patients with advanced head and neck cancer in a clinical trial funded by the National Institutes of Health. He also assisted his father, Marshall Strome, M.D., a head and neck surgeon, in developing the technique for the world’s first human total laryngeal transplant. The elder Dr. Strome performed the transplant at The Cleveland Clinic in 1998.
Read a Q&A with Dr. Strome, in which he discusses his clinical and research interests and experience and his vision for the Department of Otorhinolaryngology-Head and Neck Surgery.
Donald E. Wilson, M.D., M.A.C.P., Vice President for Medical Affairs, University of Maryland, and Dean, School of Medicine, says, “Scott Strome is an exceptionally gifted physician-scientist who will lead the transformation of our surgical Division of Otolaryngology into a new Department of Otorhinolaryngology. We already have outstanding treatment and research programs for a wide variety of ear, nose and throat disorders. Under Dr. Strome’s leadership, this new department will become one of the finest in the country.”
Jeffrey A. Rivest, President and Chief Executive Officer of the University
of Maryland Medical Center, says, “Dr. Strome’s appointment demonstrates
our commitment to recruiting excellent physician leaders who not only provide
our patients with state-of-the-art treatment but also develop new therapies
that will significantly advance patient care in the future.”
Dr. Strome says he will build on the department’s many strengths, which include “a highly skilled and dedicated faculty.” His top priorities are providing excellent medical care, developing a top-notch research program that will help patients and educating the next generation of physicians. “We must provide the best possible care for every patient who walks through the door,” he says.
In terms of research, Dr. Strome believes immunotherapy holds the key to developing effective new treatments for cancer. “To have an impact on survival, we need to look for new ways to fight cancers on a molecular level. We are developing novel methods to stimulate the body’s immune system and manipulate certain molecular pathways to boost the anti-tumor response.”
He intends to expand the department’s clinical and research programs, recruiting sinus/skull base surgeons, pediatric ear, nose and throat specialists and physicians specializing in voice disorders as well as immunologists and tumor biologists.
Dr. Strome graduated from Dartmouth College in 1987 and received his medical degree from Harvard Medical School in 1991. He completed a combined six-year internship/residency program at the University of Michigan Medical Center in 1997 and a head and neck surgery/microvascular reconstructive fellowship at the Allegheny Health Education and Research Foundation in Pittsburgh in 1998 before joining the faculty of the Mayo Clinic College of Medicine.
At the Mayo Clinic, Dr. Strome started a departmental “free flap” program (surgically transferring tissue and bone from one part of the body to another) to perform reconstructive surgery for head and neck cancer patients. He also was instrumental in initiating the institution’s head and neck tumor board. His research is focused on studying ways to harness the body’s immune system to fight squamous cell carcinoma of the head and neck. He has also recently completed a book that explores social and ethical dilemmas that affect medical training and drug development.
Dr. Strome is the author of 56 peer-reviewed journal articles and seven book chapters and is an ad hoc reviewer for a number of journals, including Head and Neck, Cancer, Laryngoscope, and Archives of Otolaryngology-Head and Neck Surgery.
In addition to caring for patients with head and neck cancers, the University of Maryland Department of Otorhinolaryngology offers a full range of services for patients with ear, nose and throat disorders, including hearing loss, tinnitus, swallowing disorders, snoring problems and sinus ailments.